News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
77,105 Results
Type
Article (2681)
Company Profile (8)
Press Release (74416)
Section
Business (33973)
Career Advice (74)
Deals (4901)
Drug Delivery (11)
Drug Development (9133)
Employer Resources (12)
FDA (1639)
Job Trends (2206)
News (47380)
Policy (2664)
Tag
Academia (169)
Accelerated approval (7)
Adcomms (2)
Allergies (10)
Alliances (2702)
ALS (18)
Alzheimer's disease (223)
Antibody-drug conjugate (ADC) (50)
Approvals (1742)
Artificial intelligence (26)
Autoimmune disease (22)
Automation (3)
Bankruptcy (17)
Best Places to Work (2054)
Biosimilars (9)
Biotechnology (5)
Bladder cancer (44)
Brain cancer (5)
Breast cancer (134)
Cancer (815)
Cardiovascular disease (64)
Career advice (72)
Career pathing (1)
CAR-T (30)
CDC (1)
Cell therapy (72)
Cervical cancer (8)
Clinical research (8671)
Collaboration (92)
Compensation (75)
COVID-19 (242)
CRISPR (7)
C-suite (24)
Cystic fibrosis (20)
Data (1163)
Depression (14)
Diabetes (72)
Diagnostics (879)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (20)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (25)
Earnings (31921)
Editorial (4)
Employer resources (10)
Events (8292)
Executive appointments (27)
FDA (2228)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (91)
Gene editing (10)
Generative AI (2)
Gene therapy (46)
GLP-1 (146)
Government (376)
Grass and pollen (1)
Guidances (288)
Healthcare (2421)
HIV (16)
Huntington's disease (2)
IgA nephropathy (25)
Immunology and inflammation (27)
Immuno-oncology (5)
Indications (27)
Infectious disease (295)
Inflammatory bowel disease (11)
Inflation Reduction Act (1)
Influenza (23)
Intellectual property (15)
Interviews (19)
IPO (3623)
IRA (3)
Job creations (257)
Job search strategy (64)
JPM (3)
Kidney cancer (2)
Labor market (15)
Layoffs (34)
Legal (389)
Liver cancer (10)
Lung cancer (128)
Lymphoma (116)
Machine learning (4)
Management (4)
Manufacturing (38)
MASH (34)
Medical device (1771)
Medtech (1785)
Mergers & acquisitions (1368)
Metabolic disorders (211)
mRNA (6)
Multiple sclerosis (28)
NASH (2)
Neurodegenerative disease (40)
Neuropsychiatric disorders (10)
Neuroscience (366)
NextGen: Class of 2026 (598)
Non-profit (278)
Now hiring (5)
Obesity (90)
Opinion (13)
Ovarian cancer (24)
Pain (21)
Pancreatic cancer (12)
Parkinson's disease (26)
Partnered (3)
Patents (28)
Patient recruitment (27)
Peanut (5)
People (2202)
Pharmaceutical (1)
Pharmacy benefit managers (3)
Phase 1 (1937)
Phase 2 (3497)
Phase 3 (3790)
Pipeline (1835)
Policy (9)
Postmarket research (350)
Preclinical (647)
Press Release (5)
Prostate cancer (44)
Psychedelics (2)
Radiopharmaceuticals (27)
Rare diseases (93)
Real estate (312)
Recruiting (4)
Regulatory (2379)
Reports (16)
Research institute (160)
Resumes & cover letters (4)
Rett syndrome (2)
RSV (27)
Schizophrenia (21)
Series A (14)
Series B (12)
Sickle cell disease (14)
Special edition (6)
Spinal muscular atrophy (10)
Sponsored (3)
Startups (165)
Stomach cancer (2)
Supply chain (5)
Tariffs (4)
The Weekly (2)
Vaccines (88)
Venture capital (7)
Weight loss (64)
Women's health (9)
Worklife (5)
Date
Today (3)
Last 7 days (123)
Last 30 days (513)
Last 365 days (4718)
2026 (755)
2025 (4790)
2024 (5415)
2023 (6443)
2022 (7563)
2021 (7349)
2020 (6925)
2019 (5119)
2018 (3873)
2017 (3288)
2016 (2786)
2015 (3547)
2014 (2491)
2013 (1621)
2012 (1738)
2011 (2245)
2010 (1824)
Location
Africa (67)
Alabama (7)
Alaska (2)
Arizona (19)
Arkansas (1)
Asia (4734)
Australia (704)
California (1734)
Canada (464)
China (117)
Colorado (84)
Connecticut (122)
Delaware (93)
Europe (11014)
Florida (264)
Georgia (74)
Hawaii (1)
Idaho (3)
Illinois (112)
India (9)
Indiana (116)
Japan (108)
Kansas (14)
Kentucky (6)
Louisiana (11)
Maine (22)
Maryland (240)
Massachusetts (1198)
Michigan (54)
Minnesota (83)
Mississippi (1)
Missouri (20)
Montana (4)
Nevada (15)
New Hampshire (11)
New Jersey (672)
New Mexico (1)
New York (496)
North Carolina (193)
Northern California (896)
Ohio (36)
Oklahoma (1)
Oregon (3)
Pennsylvania (371)
Puerto Rico (1)
South America (119)
South Carolina (3)
Southern California (729)
Tennessee (15)
Texas (188)
United States (6397)
Utah (100)
Virginia (28)
Washington D.C. (5)
Washington State (137)
Wisconsin (18)
77,105 Results for "38".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma To Participate in the 38th Annual Roth Conference
March 3, 2026
·
10 min read
Press Releases
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026
March 3, 2026
·
1 min read
Press Releases
Gilead Sciences Announces 3.8 Percent Increase in First Quarter 2026 Dividend
February 11, 2026
·
1 min read
Press Releases
Newron Secures Up to EUR 38 Million to Advance Phase III Evenamide Program
February 16, 2026
·
9 min read
Press Releases
Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program
February 24, 2026
·
6 min read
Press Releases
Next-Generation Cancer Diagnostics Market Size Worth USD 38.36 Billion by 2034
November 18, 2025
·
1 min read
Press Releases
Step Pharma announces completion of €38 million Series C financing
October 16, 2025
·
3 min read
Press Releases
TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide
January 15, 2026
·
34 min read
Press Releases
Cumulus Neuroscience Presents Data at the International Society for CNS Clinical Trials and Methodology Autumn Conference and the 38th European College of Neuropsychopharmacology Congress
October 13, 2025
·
7 min read
Cancer
J&J’s Darzalex Faspro Notches Another Multiple Myeloma Indication, Pushing Into Frontline
Darzalex Faspro, in combination with an anti-cancer triplet, is the first anti-CD38-based regimen for newly diagnosed patients with multiple myeloma, regardless of eligibility for stem cell transplantation.
January 28, 2026
·
2 min read
·
Tristan Manalac
1 of 7,711
Next
